FDA Chief: Long-Awaited Opioid Review Still in the Works

A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency’s commissioner said Tuesday. Dr. Robert Califf wrote in a blog entry that the FDA is still studying “what revisions are needed to support appropriate use” of opioid painkillers like OxyContin and Vicodin. The update comes as part … Continue reading FDA Chief: Long-Awaited Opioid Review Still in the Works